The safety of lanreotide for neuroendocrine tumor-Reference-Cited by-同舟云学术

The safety of lanreotide for neuroendocrine tumor

Published:2018-12-24 Issue:1 Volume:18 Page:1-10
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Godara Amandeep¹,Siddiqui Nauman S.¹,Byrne Margaret M.¹,Saif Muhammad Wasif¹

Affiliation:

1. Gastrointestinal Oncology Program and Experimental therapeutics, Division of Hematology/Oncology, Tufts Medical Center - Tufts University School of Medicine, Boston, MA, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2019.1559294

Reference63 articles.

1. Somatostatin analogues in functioning gastroenteropancreatic neuroendocrine tumours: literature review, clinical recommendations and schedules

2. Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas

3. Lanreotide for the treatment of gastroenteropancreatic neuroendocrine tumors

4. Differential Diagnosis of the Patient with Unexplained Flushing/Anaphylaxis

5. Diagnostic, surgical and medical aspect of the midgut carcinoids

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Cell Molecular Pharmacodynamics of Lanreotide in Relation to Treatment Response in Patients with Gastroenteropancreatic Neuroendocrine Tumors;Cancers;2024-09-07

2. Expression of somatostatin receptors in canine and feline meningioma;Veterinary Medicine and Science;2024-07

3. An update on the safety of lanreotide autogel for the treatment of patients with neuroendocrine tumors;Expert Opinion on Drug Safety;2024-06-10

4. Design of a Bilateral Disulfurating Reagent for Unsymmetrical Polysulfidation;Angewandte Chemie;2023-05-09

5. Design of a Bilateral Disulfurating Reagent for Unsymmetrical Polysulfidation;Angewandte Chemie International Edition;2023-05-09